These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3792428)

  • 1. Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
    Kurowski M; Dunky A; Geddawi M
    Eur J Clin Pharmacol; 1986; 31(3):307-11. PubMed ID: 3792428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis.
    Kurowski M; Dunky A
    Eur J Clin Pharmacol; 1988; 34(4):401-6. PubMed ID: 3402526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pirazolac on arachidonic acid metabolism in the human synovial system.
    Kurowski M; Dunky A; Geddawi M
    Curr Med Res Opin; 1987; 10(7):494-501. PubMed ID: 3040340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transsynovial kinetics of indoprofen in patients with rheumatoid arthritis and cyclooxygenase-inhibition in vitro.
    Kurowski M; Schiemann A; Siebler D
    Int J Clin Pharmacol Res; 1988; 8(4):287-93. PubMed ID: 3141302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.
    Täuber U; Weiss C; Krause W; Acksteiner B; Matthes H
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):41-53. PubMed ID: 4029220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects.
    Carnemolla B; Cutolo M; Castellani P; Balza E; Raffanti S; Zardi L
    Arthritis Rheum; 1984 Aug; 27(8):913-21. PubMed ID: 6466396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transsynovial distribution of oxaprozin.
    Kurowski M; Thabe H
    Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.
    Koup JR; Thomas D; Tucker E; Black A; Ruderman M; Dixon JA; Kinkel A
    Eur J Clin Pharmacol; 1988; 35(2):199-202. PubMed ID: 3191939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein patterns in synovial fluid and serum in rheumatoid arthritis and osteoarthritis.
    NETTELBLADT E; SUNDBLAD L
    Arthritis Rheum; 1959 Apr; 2(2):144-51. PubMed ID: 13638175
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases.
    Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A
    Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid.
    Howell A; Sutherland R; Rolinson GN
    Clin Pharmacol Ther; 1972; 13(5):724-32. PubMed ID: 5053814
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
    Hartjen N; Bräuer L; Reiß B; Claassen H; Beileke S; Garreis F; Hoogeboom S; Tsokos M; Etzold S; Müller-Hilke B; Gelse K; Müller T; Goldring MB; Paulsen F; Schicht M
    PLoS One; 2018; 13(9):e0203502. PubMed ID: 30235245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.